Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
02:30:00 11/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 136.26 USD | +0.26% |
|
-2.84% | +56.01% |
| Market Cap | 889.37Cr 797.59Cr 735.06Cr 667.55Cr 1.26TCr 83TCr 1.3TCr 8.8TCr 3.51TCr 45TCr 3.34TCr 3.27TCr 1,41200Cr | P/E 2026 * |
26.8x | P/E 2027 * | 494x |
|---|---|---|---|---|---|
| Enterprise Value | 831.75Cr 745.91Cr 687.43Cr 624.3Cr 1.18TCr 78TCr 1.21TCr 8.23TCr 3.28TCr 42TCr 3.12TCr 3.06TCr 1,32100Cr | EV / Sales 2026 * |
14.7x | EV / Sales 2027 * | 34.7x |
| Free-Float |
96.86% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTGX | Delayed | |
CBOE
| PTGX | Real-time | |
|
Tradegate
| PGF | Real-time |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | +0.26% | ||
| 1 week | -2.84% | ||
| Current month | -5.93% | ||
| 1 month | -5.20% | ||
| 3 months | -9.16% | ||
| 6 months | +37.14% | ||
| Current year | +56.01% |
| 1 week | 128 |  | 143.3 |
| 1 month | 126.39 | | 152.18 |
| Current year | 77 | | 160.81 |
| 1 year | 77 | | 160.81 |
| 3 years | 15.05 | | 160.81 |
| 5 years | 6.91 | | 160.81 |
| 10 years | 4.47 | | 160.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 01/12/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 18/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 01/12/2008 |
Harold Selick
CHM | Chairman | 71 | 19/03/2014 |
William Waddill
BRD | Director/Board Member | 68 | 01/07/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Exercice | Chief Financial Officer | 1,75,887 | 0.2718% | ||
| 10/09/26 | Exercice | Chief Executive Officer | 21,834 | 0.0337% | ||
| 03/09/26 | Don | Chief Executive Officer | -510 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.26% | -2.84% | +63.72% | +779.66% | 887.02Cr | |
| +0.01% | +11.10% | +60.83% | +70.43% | 6.82TCr | |
| +1.22% | +9.56% | +15.97% | +90.23% | 5.98TCr | |
| +0.24% | +1.35% | +23.78% | +97.55% | 5.61TCr | |
| +1.60% | +19.44% | +28.80% | +112.95% | 4.77TCr | |
| -1.32% | +4.78% | +29.15% | +40.40% | 4.6TCr | |
| -3.54% | -0.60% | +207.76% | +879.50% | 4.33TCr | |
| -3.33% | +6.90% | +22.78% | +48.07% | 3.57TCr | |
| -2.19% | -3.71% | +90.94% | +66.33% | 3.47TCr | |
| +2.92% | +14.41% | -37.74% | +403.12% | 2.55TCr | |
| Average | -0.41% | +4.63% | +50.60% | +258.82% | 4TCr | |
| Weighted average by Cap. | -0.40% | +5.33% | +51.01% | +193.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57Cr 51Cr 47Cr 43Cr 81Cr 5.32TCr 83Cr 561.32Cr 223.64Cr 2.85TCr 212.87Cr 208.36Cr 9.01TCr | 24Cr 22Cr 20Cr 18Cr 34Cr 2.25TCr 35Cr 237.75Cr 95Cr 1.21TCr 90Cr 88Cr 3.82TCr |
| Net income | 35Cr 32Cr 29Cr 27Cr 50Cr 3.31TCr 52Cr 349.87Cr 139.4Cr 1.78TCr 132.68Cr 129.87Cr 5.61TCr | 4.27Cr 3.83Cr 3.53Cr 3.2Cr 6.06Cr 400.19Cr 6.23Cr 42Cr 17Cr 214.41Cr 16Cr 16Cr 677.8Cr |
| Net Debt | -58Cr -52Cr -48Cr -43Cr -82Cr -5.4TCr -84Cr -570.25Cr -227.2Cr -2.89TCr -216.26Cr -211.67Cr -9.15TCr | -57Cr -51Cr -47Cr -43Cr -81Cr -5.32TCr -83Cr -561.26Cr -223.62Cr -2.85TCr -212.85Cr -208.33Cr -9.01TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | $136.26 | +0.26% | 5,28,488 |
| 09/26/09 | $135.90 | +2.92% | 6,07,111 |
| 06/26/06 | $132.04 | -2.38% | 9,72,945 |
| 05/26/05 | $135.26 | -5.66% | 5,84,678 |
| 04/26/04 | $143.37 | +2.23% | 7,77,232 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
